Core Viewpoint - The article emphasizes the increasing incidence of lymphoma due to the aging population in China, while highlighting that modern medical advancements have made it a controllable disease. Awareness of health, attention to abnormal body signals, and timely medical consultation are crucial in addressing lymphoma [1]. Group 1: Types of Lymphoma - Lymphoma is primarily categorized into Hodgkin lymphoma and non-Hodgkin lymphoma, with Hodgkin lymphoma being relatively rare, accounting for about 10% of cases. Non-Hodgkin lymphoma is more common and complex, with various subtypes. The distinction between these two types is fundamental for diagnosis and influences treatment strategies and prognosis [2]. Group 2: Symptoms of Lymphoma - The most common initial symptoms of lymphoma include progressive, painless, and hard lymph node enlargement in areas such as the neck, armpit, or groin. Other clinical symptoms may include fever, night sweats, and weight loss [3]. Group 3: Diagnosis of Lymphoma - Lymph node biopsy is the gold standard for diagnosing lymphoma, where a sample of affected tissue is examined to confirm the presence of lymphoma and determine its subtype. Additional tests, including blood, imaging, and bone marrow examinations, may be conducted to assess the condition [5]. Group 4: Treatment of Lymphoma - The main treatment modalities for lymphoma include chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Chemotherapy is a systemic treatment that targets rapidly proliferating malignant cells, while radiotherapy is a localized treatment that uses high-energy rays to damage tumor DNA. Targeted therapy specifically interferes with tumor cell growth, and immunotherapy enhances the body's immune response against tumors [5]. Group 5: Recovery and Management - With advancements in medical technology, the cure rate for lymphoma has significantly improved. Most patients achieve good outcomes through standardized and comprehensive treatment. Post-treatment recovery is also vital, requiring regular check-ups, exercise, and maintaining a positive lifestyle [6]. Group 6: Expert Commentary - The article provides a detailed overview of lymphoma types, symptoms, diagnostic methods, and treatment options, while emphasizing the importance of recovery management, such as regular check-ups and healthy living. The structure is clear and content-rich, making it suitable for public reading and helping to alleviate fears and boost confidence in overcoming the disease [7].

Core Viewpoint - Tumor immunotherapy, particularly immune checkpoint blockade (ICB) targeting the PD-1/PD-L1 pathway, shows promise in treating advanced cancers but is limited by insufficient response rates. Recent findings suggest that Gasdermin D-mediated pyroptosis can trigger a robust systemic immune response, with only 15% of pyroptotic tumor cells capable of eliminating the entire tumor, presenting a new strategy for enhancing anti-tumor immunity [2][3][10]. Summary by Sections Research Development - A new self-luminous photodynamic therapy system, CC@PDC, has been developed to efficiently activate pyroptosis and stimulate anti-tumor immunity. This system, when used in conjunction with anti-PD-L1 antibodies, demonstrates superior anti-tumor and immune effects, offering a novel strategy for cancer treatment [3][10]. Mechanism and Composition - The CC@PDC system is designed with efficient resonance energy transfer, effective generation of singlet oxygen (1 O₂), and strong pyroptosis induction capabilities. It consists of amphiphilic porphyrin lipids, camptothecin derivatives, and a targeted assembly that encapsulates oleic acid-modified calcium peroxide and a specific compound to enhance its efficacy in acidic tumor microenvironments [7][10]. Key Findings - The study highlights that the camptothecin-enhanced self-luminous photodynamic chemotherapy can synergistically induce tumor cell pyroptosis and, when combined with anti-PD-L1 antibodies, significantly enhances the anti-tumor immune response, providing a promising new approach for cancer therapy [10][11].